Filing Details
- Accession Number:
- 0001562180-19-003220
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-06-03 16:03:11
- Reporting Period:
- 2019-05-30
- Accepted Time:
- 2019-06-03 16:03:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1100412 | Array Biopharma Inc | ARRY | Pharmaceutical Preparations (2834) | 841460811 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1620368 | Victor Sandor | C/O Array Biopharma Inc. 3200 Walnut Street Boulder CO 80301 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-05-30 | 15,728 | $3.65 | 225,271 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-05-30 | 15,728 | $27.50 | 209,543 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-06-03 | 36,134 | $3.65 | 245,677 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-06-03 | 36,134 | $27.58 | 209,543 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-05-30 | 15,728 | $0.00 | 15,728 | $3.65 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-06-03 | 36,134 | $0.00 | 36,134 | $3.65 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 36,134 | 2024-09-22 | No | 4 | M | Direct | |
| 0 | 2024-09-22 | No | 4 | M | Direct |
Footnotes
- These trades were made pursuant to a Rule 10b5-1 trading plan.
- The price reported for these shares is the weighted average sale price of transactions made at prices from $27.50 to $27.67. Details of actual prices for shares sold are available from the Issuer upon request.
- The option vested in four equal annual installments beginning on September 22, 2015.
Billionaire Hedge Funds
